Your session is about to expire
← Back to Search
Home-Based e-Rehabilitation for Osteoarthritis (ReDI@Home Trial)
N/A
Waitlist Available
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have activity limitations because of joint pain
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 0- weeks (pre-intervention), 9-weeks (post-intervention) and 6- and 12-months following randomization.
Awards & highlights
ReDI@Home Trial Summary
This trial will help to improve access to rehabilitation for rural residents with OA by examining the feasibility of home-based e-Rehabilitation delivered via smart phone.
Who is the study for?
This trial is for adults with moderate to advanced hip or knee osteoarthritis who live in rural areas, are not eligible for joint replacement within a year, and can use a smartphone or tablet. They should need guided exercise but be able to move around on their own, even if they need aids.Check my eligibility
What is being tested?
The study tests two home-based e-Rehabilitation programs delivered via smartphone for people with osteoarthritis. One program has low intensity (eRP-LO) and the other high intensity (eRP-HI), aiming to see which improves self-management and patient outcomes more effectively.See study design
What are the potential side effects?
Since this trial involves exercise and self-management strategies without medication, side effects may include muscle soreness or strain from physical activity. However, specific side effects will depend on individual health conditions.
ReDI@Home Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My joint pain limits my daily activities.
ReDI@Home Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 0- weeks (pre-intervention), 9-weeks (post-intervention) and 6- and 12-months following randomization.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 0- weeks (pre-intervention), 9-weeks (post-intervention) and 6- and 12-months following randomization.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Patient Activation Measure from baseline to post intervention and 6-months and 12-months
Secondary outcome measures
Canadian Longitudinal Study of Aging
Change in 30-second Chair Stand test from baseline to post intervention and 6-months and 12-months
Change in Global Rating of Change from baseline to post intervention and 6-months and 12-months
+7 moreReDI@Home Trial Design
2Treatment groups
Experimental Treatment
Group I: eRP-LOw Intensity (eRP-LO)Experimental Treatment2 Interventions
an 8-week intervention that includes FOUR virtual visits with a physiotherapist
Group II: eRP-HIgh Intensity (eRP-HI)Experimental Treatment2 Interventions
an 8-week intervention that includes EIGHT virtual visits with a physiotherapist
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
progressive resistance exercise
2002
Completed Phase 2
~30
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
886 Previous Clinical Trials
384,666 Total Patients Enrolled
9 Trials studying Osteoarthritis
670 Patients Enrolled for Osteoarthritis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have moderate to advanced hip or knee arthritis and am not waiting for joint replacement surgery within a year.My joint pain limits my daily activities.I need guided exercise but can walk in the community with or without help.I experience hip or knee pain several days a week.I am not eligible for joint surgery due to uncontrolled health issues like diabetes or high blood pressure.
Research Study Groups:
This trial has the following groups:- Group 1: eRP-HIgh Intensity (eRP-HI)
- Group 2: eRP-LOw Intensity (eRP-LO)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities left to participate in this clinical exploration?
"Affirmative. Clinicaltrials.gov lists this study as actively recruiting patients, having first been posted on December 9th 2021 and last updated June 13th 2022. The research team seeks to enrol 120 individuals across one site."
Answered by AI
What is the upper limit of participants in this research project?
"Indeed, the information posted to clinicaltrials.gov indicates that recruitment of participants is currently underway. This medical trial was initially announced on December 9th 2021 and most recently updated on June 13th 2022; 120 individuals are sought from a single research site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger